The present study indicates that AT1R/NOX/ROS/MAPK signaling pathway is involved in DOX-induced cardiotoxicity and confirmed the previous finding that Val treatment significantly attenuated DOX-induced cardiotoxicity, without affecting the anti-tumor effect of DOX. Here, AGTR1 is linked to neoplasm.